CATXPerspective Therapeutics Inc. Common Stock
3.300USD-5.17%Mkt Cap: 376.70M $P/E: —3d ago
Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial …
Industry Peers
Medical Devices$203.17BUSDP/E 37.7
$126.37BUSDP/E 34.2
$119.49BUSDP/E 25.0
$73.00BUSDP/E 20.4
$48.43BUSDP/E 19.9
$51.70BUSDP/E 53.4
$34.85BUSDP/E 36.5
$34.04BUSDP/E 17.2
$25.08BUSDP/E 20.7
$26.80BUSDP/E 20.8
$23.20BUSDP/E 29.1
$19.26BUSDP/E 24.5
$12.81BUSDP/E 79.7
$12.25BUSDP/E 19.9
$11.48BUSDP/E 19.8
$11.67BUSDP/E 22.2
$10.91BUSD
$10.01BUSDP/E 17.1
$10.28BUSDP/E 27.5
$10.17BUSDP/E 46.3
Key Statistics
Company
Market Cap376.70M $
Enterprise Value143.79M $
Revenue (TTM)409.00K $
Gross Profit-95.77M $
Net Income (TTM)-103.12M $
Revenue/Share0.0040 USD
Last Price3.300 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees163
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.24
PEG—
EV/EBITDA-1.19
EV/Revenue351.56
P/S921.03
P/B1.16
EPS (TTM)-1.33
EPS (Forward)-1.02
52W Range
1.96032% of range6.160
52W High6.160 USD
52W Low1.960 USD
Profitability
Gross Margin0.00%
Oper. Margin-36120.99%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-49.81%
ROA-38.63%
Growth
Revenue Growth-72.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-82.48M $
CapEx (TTM)12.75M $
FCF Margin-16974.48%
FCF Yield-18.43%
Net Debt-232.91M $
Net Debt/EBITDA1.92
Balance Sheet
Debt/Equity0.02
Current Ratio6.61
Quick Ratio6.49
Book Value/Sh2.839 USD
Cash/Share2.075 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 17, 2024
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.53 USD
Upside (mean)+279.8%
Target Range5.000 USD – 18.00 USD
$5.000+279.8% to mean$18.00
# Analysts15
Ownership
Shares Out.114.15M
Float64.19M
Insiders10.80%
Institutions85.88%
Short Interest
Short Ratio15.0d
Short % Float24.58%
Short % Out.20.57%
Shares Short23.47M
Short (prev mo.)22.72M
Technical
SMA 503.101 (+6.4%)
SMA 2003.519 (-6.2%)
Beta1.80
S&P 52W Chg19.18%
Avg Vol (30d)1.32M
Avg Vol (10d)1.22M
Technical Indicators
RSI (14)56.7
MACD0.0513
MACD Signal-0.0017
MACD Hist.+0.0529
BB Upper3.392 USD
BB Middle3.049 USD
BB Lower2.706 USD
BB Width22.53%
ATR (14)0.1910 USD
Vol Ratio (20d)1.09x